Low‐quality evidence suggests that compared with conventional therapy alone, the use of CRRT may be associated with a lower mortality rate, the incidence of VAP, ICU length of stay, mechanical ventilation time, EVLWI, APACHE II score, TNF‐α, and IL‐6 and may be related to better respiratory function. The gene discussed is TNF; the disease is ventilator-associated pneumonia.